EP4709370A2 - Stat-abbauer und verwendungen davon - Google Patents
Stat-abbauer und verwendungen davonInfo
- Publication number
- EP4709370A2 EP4709370A2 EP24804192.3A EP24804192A EP4709370A2 EP 4709370 A2 EP4709370 A2 EP 4709370A2 EP 24804192 A EP24804192 A EP 24804192A EP 4709370 A2 EP4709370 A2 EP 4709370A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- alkyl
- halo
- phenyl
- compound
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363465055P | 2023-05-09 | 2023-05-09 | |
| PCT/US2024/028326 WO2024233639A2 (en) | 2023-05-09 | 2024-05-08 | Stat degraders and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4709370A2 true EP4709370A2 (de) | 2026-03-18 |
Family
ID=93431152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24804192.3A Pending EP4709370A2 (de) | 2023-05-09 | 2024-05-08 | Stat-abbauer und verwendungen davon |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4709370A2 (de) |
| WO (1) | WO2024233639A2 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020198435A1 (en) * | 2019-03-26 | 2020-10-01 | The Regents Of The University Of Michigan | Small molecule degraders of stat3 |
| CA3170503A1 (en) * | 2020-03-17 | 2021-09-23 | Nan JI | Stat degraders and uses thereof |
| IL301830A (en) * | 2020-10-07 | 2023-06-01 | Kymera Therapeutics Inc | Stat degraders and uses thereof |
| KR20240167786A (ko) * | 2022-01-10 | 2024-11-28 | 레클루딕스 파마, 인크. | Stat 조정제 및 그의 용도 |
-
2024
- 2024-05-08 EP EP24804192.3A patent/EP4709370A2/de active Pending
- 2024-05-08 WO PCT/US2024/028326 patent/WO2024233639A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024233639A2 (en) | 2024-11-14 |
| WO2024233639A3 (en) | 2025-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3226206A1 (en) | Shp2 inhibitor and use thereof | |
| US20230265116A1 (en) | Degradation of (egfr) by conjugation of egfr inhibitors with e3 ligase ligand and methods of use | |
| CA2961607C (en) | Mk2 inhibitors and uses thereof | |
| RU2610840C2 (ru) | Тиазолопиримидины | |
| US20250215030A1 (en) | Stat modulators and uses thereof | |
| JP2022518860A (ja) | 免疫調節剤、組成物およびその使用方法 | |
| CN115304606B (zh) | 一种同时靶向btk和gspt1蛋白的降解剂 | |
| US10167281B2 (en) | Substituted thiazole or oxazole P2X7 receptor antagonists | |
| US8691804B2 (en) | Azetidines and cyclobutanes as histamine H3 receptor antagonists | |
| CA2890983A1 (en) | Heteroaryl substituted pyridyl compounds useful as kinase modulators | |
| KR20190034564A (ko) | 약학적 화합물 | |
| IL283290B1 (en) | Cyclic urea | |
| CA3054324C (en) | Tri-cycle compound and applications thereof | |
| TW202237597A (zh) | 新型egfr降解劑 | |
| AU2019344922B2 (en) | O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors | |
| KR20150092156A (ko) | Cb2 수용체 작용제로서 신규한 피라진 유도체 | |
| JP2006522824A (ja) | 炎症性疾患を処置するために有用なβ−カルボリン | |
| AU2005243188A1 (en) | Beta-carbolines useful for treating inflammatory disease | |
| AU2022271927A1 (en) | Compound having anti-tumor activity and use thereof | |
| JP7734147B2 (ja) | Sstr4アゴニストとしてのn-(ヘテロシクリル及びヘテロシクリルアルキル)-3-ベンジルピリジン-2-アミン誘導体 | |
| WO2024238598A2 (en) | Stat degraders and uses thereof | |
| JP2023545065A (ja) | オートタキシン抑制剤化合物 | |
| EP4709370A2 (de) | Stat-abbauer und verwendungen davon | |
| EP4262975B1 (de) | Heterocyclische derivate als p2x7-rezeptor-antagonisten | |
| WO2024238603A2 (en) | Stat degraders and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251102 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |